Literature DB >> 7789344

Effects of psychosocial interventions with adult cancer patients: a meta-analysis of randomized experiments.

T J Meyer1, M M Mark.   

Abstract

Meta-analytic methods were used to synthesize the results of published randomized, controlled-outcome studies of psychosocial interventions with adult cancer patients. Forty-five studies reporting 62 treatment-control comparisons were identified. Samples were predominantly White, female, and from the United States. Beneficial effect size ds were .24 for emotional adjustment measures, .19 for functional adjustment measures, .26 for measures of treatment- and disease-related symptoms, and .28 for compound and global measures. The effect size of .17 found for medical measures was not statistically significant for the few reporting studies. Effect sizes for treatment-control comparisons did not significantly differ among several categories of treatment: behavioral interventions, nonbehavioral counseling and therapy, informational and educational methods, organized social support provided by other patients, and other nonhospice interventions.

Entities:  

Mesh:

Year:  1995        PMID: 7789344     DOI: 10.1037//0278-6133.14.2.101

Source DB:  PubMed          Journal:  Health Psychol        ISSN: 0278-6133            Impact factor:   4.267


  130 in total

1.  Information and support for women following the primary treatment of breast cancer.

Authors:  Jane C A Raupach; Janet E Hiller
Journal:  Health Expect       Date:  2002-12       Impact factor: 3.377

2.  Going quasi: the premature disclosure effect in a randomized clinical trial.

Authors:  Shauna L Shapiro; Aurelio J Figueredo; Opher Caspi; Gary E Schwartz; Richard R Bootzin; Ana Maria Lopez; Douglas Lake
Journal:  J Behav Med       Date:  2002-12

3.  The Symptom Cluster of Sleep, Fatigue and Depressive Symptoms in Breast Cancer Patients: Severity of the Problem and Treatment Options.

Authors:  Lavinia Fiorentino; Michelle Rissling; Lianqi Liu; Sonia Ancoli-Israel
Journal:  Drug Discov Today Dis Models       Date:  2011

4.  Biobehavioral, immune, and health benefits following recurrence for psychological intervention participants.

Authors:  Barbara L Andersen; Lisa M Thornton; Charles L Shapiro; William B Farrar; Bethany L Mundy; Hae-Chung Yang; William E Carson
Journal:  Clin Cancer Res       Date:  2010-06-08       Impact factor: 12.531

5.  "Well, have I got cancer or haven't I?" The psycho-social issues for women diagnosed with ductal carcinoma in situ.

Authors:  Simone De Morgan; Sally Redman; Kate J White; Burcu Cakir; John Boyages
Journal:  Health Expect       Date:  2002-12       Impact factor: 3.377

Review 6.  A systematic review of large-scale surveys of cancer survivors conducted in North America, 2000-2011.

Authors:  Catherine C Lerro; Kevin D Stein; Tenbroeck Smith; Katherine S Virgo
Journal:  J Cancer Surviv       Date:  2012-03-03       Impact factor: 4.442

Review 7.  Management of primary breast cancer.

Authors:  A Melville; A Liberati; R Grilli; T Sheldon
Journal:  Qual Health Care       Date:  1996-12

8.  Efficacy of an intervention for fatigue and sleep disturbance during cancer chemotherapy.

Authors:  Andrea Barsevick; Susan L Beck; William N Dudley; Bob Wong; Ann M Berger; Kyra Whitmer; Tracey Newhall; Susan Brown; Katie Stewart
Journal:  J Pain Symptom Manage       Date:  2010-06-18       Impact factor: 3.612

9.  Pilot randomized controlled trial of a patient-controlled cognitive-behavioral intervention for the pain, fatigue, and sleep disturbance symptom cluster in cancer.

Authors:  Kristine L Kwekkeboom; Kristen Abbott-Anderson; Catherine Cherwin; Rachel Roiland; Ronald C Serlin; Sandra E Ward
Journal:  J Pain Symptom Manage       Date:  2012-07-07       Impact factor: 3.612

10.  Dissemination of an evidence-based treatment for cancer patients: training is the necessary first step.

Authors:  Brittany M Brothers; Kristen M Carpenter; Rebecca A Shelby; Lisa M Thornton; Georita M Frierson; Kyle L Patterson; Barbara L Andersen
Journal:  Transl Behav Med       Date:  2015-03       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.